🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Genetic Predisposition to Disease

Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site📍 Durham Duke University Genes and Environment in Multiple Sclerosis NCT01353547n/a5 sites📍 Bethesda📍 Boston📍 Boston Columbia University Shanghai High Myopia Study NCT03062085n/a1 site📍 Shanghai Shanghai High Myopia Study Group · Tests: Cataract Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy NCT06554288Phase 11 site📍 Kansas City Children's Mercy Hospital Kansas City · Tests: Trihexyphenidyl Vascular Disease Discovery Protocol NCT03538639n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer NCT04903782n/a3 sites📍 Newcastle📍 Sydney📍 Sydney Sydney Children's Hospitals Network · Tests: Family-based whole genome sequencing Precision Medicine in the Prostate Cancer Care Pathway NCT04763317n/a1 site📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Prostate cancer risk gene panel Genetic Predisposition in Cerebral Palsy NCT05317234NA2 sites📍 Bron📍 Grenoble Hospices Civils de Lyon · Tests: Whole-exome sequencing Video Capsule Examination in Patients With Lynch Syndrome NCT06712095NA1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Video capsule investigation Outcomes of Health Care Transition for AYA With a Cancer Predisposition NCT07456904n/a1 site📍 Memphis St. Jude Children's Research Hospital · Tests: Readiness Assessment, Transition Outcomes Survey A, Transition Outcomes Survey B Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score NCT07490067Phase 41 site📍 Ann Arbor University of Michigan · Tests: Metoprolol Succinate, Beta-Blocker Polygenic Score, Illumina Infinium Global Diversity Array with Enhanced Pharmacogeno… Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study NCT07621445n/a1 site📍 Changsha Second Xiangya Hospital of Central South University Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation NCT03667417n/a1 site📍 Marseille Institut Paoli-Calmettes · Tests: Questionnaires Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage NCT06993142NA2 sites📍 Rochester📍 Nijmegen Radboud University Medical Center · Tests: Increase of physical activity volume and intensity with the use of a motivational smartphone application Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169n/a2 sites📍 New Delhi📍 Puducherry University of Geneva, Switzerland Predicting Pre-dementia NCT07516119n/a1 site📍 San Diego Prevention Research Consortium Corp. Prostate Cancer Genetic Risk Evaluation and Screening Study NCT05129605n/a1 site📍 Boston Massachusetts General Hospital · Tests: Prostate cancer screening Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms NCT05746182n/a3 sites📍 Los Angeles📍 San Diego📍 San Francisco University of California, San Francisco · Tests: Hereditary Cancer Panel The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). NCT06636526n/a3 sites📍 Sutton📍 London📍 Sutton Institute of Cancer Research, United Kingdom · Tests: The i4i PRODICT® test., Prostate cancer screening, MRI Scan, Prostate Biopsy Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) NCT07284641Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hematopoietic stem cell transplant (HSCT) Effects of Sirolimus on Asymptomatic ApoE4 Carriers NCT07728175Phase 11 site📍 Columbia University of Missouri-Columbia · Tests: Sirolimus (rapamycin), Placebo Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes NCT04731857n/a1 site📍 Tübingen University Hospital Tuebingen · Tests: Retrospective data analysis Pancreatic Cancer Early Detection Consortium NCT04970056n/a62 sites📍 Phoenix📍 Scottsdale📍 Burbank Arbor Research Collaborative for Health Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419NA1 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University · Tests: GLP-1 receptor agonist, responders group and nonresponders group Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition NCT05849155n/a1 site📍 Memphis St. Jude Children's Research Hospital Studies of Disorders With Increased Susceptibility to Fungal Infections NCT01222741n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED) NCT06591260n/a1 site📍 Milan Scientific Institute San Raffaele · Tests: support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes NCT06586203NA2 sites📍 Montreal📍 Montreal Optithera · Tests: Polygenic Risk Score Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health NCT07087431NA1 site📍 Boston Massachusetts General Hospital · Tests: Immediate disclosure of CAD PRS results, Deferred Disclosure of CAD PRS results Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy